Haemophilia Area Commercial Lead
No salary listed
Senior
Bachelor's
New Delhi, Delhi, India
In PersonField-based role in New Delhi.
Sales & Account ManagementField Sales
About the job
Requirements
- A graduate degree in Science or Pharmacy is required.
- Seven to ten years of experience in pharmaceutical, channel, or institutional sales is required.
- Experience in haemophilia, rare disease, or specialty care is preferred.
- Demonstrated ability to manage key accounts and drive patient-level outcomes is required.
- Demonstrated ability to lead by example and foster a customer-first, customer-centric culture is required.
- Experience implementing strategies that enhance customer satisfaction and loyalty is required.
- Ability to adapt strategies in real time based on customer feedback and market changes is required.
- Ability to adapt to new ways of working, including Agile methodologies, is required.
- Ability to leverage Agile methodologies for cross-team projects and initiatives is required.
Responsibilities
- Achieve sales and profitability targets and plan and deploy financial and other resources for business growth in alignment with company policy and objectives.
- Achieve sales objectives for assigned brands and regional goals while delivering the portfolio mix set by the organization.
- Conduct face-to-face and digital interactions with healthcare professionals to promote rare disease awareness and Sanofi products.
- Track and analyze sales performance metrics to generate business insights and accurate forecasts.
- Monitor brand market share against competitors, align local tactics with national strategies, and provide regular feedback to marketing on strategy effectiveness.
- Follow guidance on healthcare-professional reach, call load, call average, OCCP plans, and CPA for A and B customers to ensure effective customer engagement through face-to-face and digital channels.
- Record customer interactions and insights in the customer relationship management system.
- Support marketing in developing local campaigns and initiatives to expand market share, including specific communications, medical or scientific symposia, and key-account strategies.
- Support relevant medical representative activities.
- Organize, implement, and review sales-tactic rollouts through the monthly promotional cycle and align stakeholders to drive demand generation and sales realization.
- Maintain deep understanding of assigned products and portfolio, including key differentiators versus competitors.
- Deliver clear, compliant, and effective product presentations to healthcare professionals.
- Ensure all activities comply with Sanofi policy, industry regulations, and local laws.
- Maintain proper records of promotional activities and expenses.
- Report adverse drug reactions to Pharmacovigilance within the specified time and coordinate with the function to resolve or handle the situation.
- Understand the pillars of the haemophilia business, bleeding guidelines from the World Federation of Hemophilia, and funding channels including central and state funding, ESIC, Army, CGHS, Railways, and other CARE segments.
- Ensure strategic account-management practices through multistakeholder engagement so Sanofi is viewed as a value partner for rare disease therapy areas.
- Develop deep stakeholder understanding for each account to assess access to rare disease therapy.
- Collaborate with Marketing, Medical Affairs, Market Access, Tender, Trade, and Public Affairs teams to build a favorable ecosystem for healthcare professionals and key decision-makers supporting rare disease treatment.
Desired Qualifications
- Experience in haemophilia, rare disease, or specialty care.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave